CNO Financial Group, Inc. (CNO) — Fair Value Analysis

Base-case fair value (P50): $44.33 · Current price: $55.16 · Verdict: Overvalued

The Verdict on CNO

Based on Monte Carlo simulations, CNO Financial Group (CNO) is currently assessed as Fairly Valued. Our analysis indicates that the company's current trading price of $55.16 is closely aligned with its median fair value (P50) of $44.33. This implies a -19.6% gap, suggesting the market is largely reflecting its intrinsic value as derived from our forward-looking models. The Monte Carlo approach evaluates thousands of potential future scenarios, incorporating various financial drivers and market conditions to establish a robust range of probable valuations for CNO. This alignment between $55.16 and $44.33 is a key takeaway for investors considering CNO at its present valuation.

How CNO stacks up against peers

While CNO's sector is unrated and its operational/financial health also currently stands as unrated, our Monte Carlo analysis still provides a critical quantitative benchmark for its valuation. The consistent outcome, where CNO's $55.16 sits close to its $44.33 median fair value, suggests a balance between current market sentiment and a wide range of potential future outcomes modeled for the company. Without a specific quality tier rating, a direct qualitative comparison against sector peers is limited. However, the simulation’s output provides an independent assessment of CNO's intrinsic worth relative to its current share price, indicating a lack of significant overvaluation or undervaluation at $55.16.

What this means for investors

For investors, the "Fairly Valued" verdict for CNO, with its $55.16 near $44.33, suggests that new positions may not offer a substantial immediate arbitrage opportunity based on our current Monte Carlo output. The -19.6% indicates that the stock is trading within a tight range of its median intrinsic value. Investors should consider that while the current price appears fair, market dynamics can shift. For those seeking deeper insights into CNO's valuation drivers and potential price movements under varying conditions, including specific bear-case and bull-case scenarios, a more granular analysis is required. Sign up for a free FairCurve account to see the full bear/bull distribution and track CNO's fair value as new fundamentals are released.

Frequently Asked Questions

Is CNO overvalued or undervalued right now?

CNO is currently assessed as Fairly Valued, with its current price of $55.16 closely matching the median fair value (P50) of $44.33 derived from Monte Carlo simulations.

What is the bear case and bull case for CNO?

The full Monte Carlo distribution, including specific bear (P10) and bull (P90) target prices, along with the probability of achieving upside, is available with a free FairCurve account. We do not provide specific dollar values here.

How does FairCurve calculate CNO's fair value?

FairCurve calculates CNO's fair value using sophisticated Monte Carlo simulations, running thousands of forward-looking scenarios to determine a comprehensive range of potential intrinsic values.

How can I track CNO's fair value as it changes?

You can add CNO to a free FairCurve watchlist to receive daily fair-value updates and instant re-valuation alerts whenever new earnings or significant fundamental data are released.